1. Efectividad de ivacaftor en vida real en niños con fibrosis quística y mutación G551D;Gomez-Pastrana;An Pediatr (Barc),2019
2. Longitudinal trends in real-world outcomes following initiation of ivacaftor: a cohort study from the cystic fibrosis registry of Ireland;Kirwan;Ann Am Thorac Soc,2018
3. Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis;Quintero;An Pediatr (Barc),2018
4. Usage of unpublished paediatric data;Saint-Raymond;Arch Dis Child,2016
5. EMA List of recommended changes to product information for nationally-approved medicines. Available from: http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Article_45_and_previous_Worksharing/CMDh-124-2008-Rev4.xls [accessed 26.12.18].